Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ropivacaine in periarticular local infiltration analgesia for total knee arthroplasty without tourniquet
2017-000180-32Phase 4Completed
- Sponsor
- Sint Maartenskliniek
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in knee osteoarthritis (OA), sponsored by Sint Maartenskliniek. Primary endpoints: Mean total maximum serum concentration of ropivacaine (Cmax) and Mean unbound maximum serum concentration of ropivacaine (Cumax). Started Jan 2017; status: completed.
02
Drugs
ropivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2017-000180-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000180-32.